Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Glide Pharma, the specialty pharmaceutical company, secures ?2.3 million
August 31st, 2007
Glide PharmaTM, the specialty pharmaceutical company developing products based on its innovative needle-free Glide SDI(tm) drug delivery system, has raised '2.3 million. The round involved existing shareholders, such as Oxford Technology 4 VCT, as well as new investors including Oxford Capital Partners. Under a separate agreement, Glide Pharma has also entered into an exclusive licence and distribution deal with Paladin Labs Inc, a leading Canadian specialty pharmaceutical company, for Glide Pharma products in Canada. Located at Milton Park, Oxfordshire, Glide Pharma has developed the Glide SDI, an easy to use drug delivery system that injects drugs in solid dosage form...
Source: Drug Week (2007-08-31)
|
